We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Laser Scattering Technique Detects Single Molecules

By LabMedica International staff writers
Posted on 21 Sep 2014
Print article
Image: Investigators identified individual unlabeled proteins by the weak shadow that the biomolecules produce when they scatter laser light (Photo courtesy of the Max Planck Institute for the Science of Light).
Image: Investigators identified individual unlabeled proteins by the weak shadow that the biomolecules produce when they scatter laser light (Photo courtesy of the Max Planck Institute for the Science of Light).
A recent paper described a novel technique for the label-free detection of single biomolecules such as tumor markers, proteins, or RNA fragments.

Investigators at the Max Planck Institute for the Science of Light (Erlangen, Germany) adapted a method called interferometric detection of scattering (iSCAT) to achieve the goal of label-free single molecule detection.

In this approach, which was described fully in the July 29, 2014, online edition of the journal Nature Communications, the investigators directed laser light onto a microscope slide on which proteins of interest had been captured with appropriate biochemical lures. The bound proteins scattered the laser light, thus casting a shadow. By comparing shadow diagrams before and after binding of the proteins of interest, the investigators could identify target proteins, which stood out clearly from the background as dark spots, even though the shadow of the protein was only one ten-thousandth or even one hundred-thousandth as dark as the background.

“In our method the scattering image of a protein is amplified and stripped of background noise. iSCAT not only promises more sensitive diagnosis of diseases such as cancers, but will also shed light on many fundamental biochemical processes in nature,” said senior author Dr. Vahid Sandoghdar, director of the nano-optics division of the Max Planck Institute for the Science of Light. “Until now it was thought that if you want to detect scattered light from nanoparticles, you have to eliminate all background light. However, in recent years we have realized that it is more advantageous to illuminate the sample strongly and visualize the feeble signal of a tiny nanoparticle as a shadow against the intense background light. The strength of our method lies not only in the fact that it is so sensitive and that we can count target proteins in a sample, iSCAT also shows us the exact position of particles.”

Related Links:

Max Planck Institute for the Science of Light


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.